background
china
experienc
outbreak
novel
human
coronaviru
sinc
decemb
quickli
becam
worldwid
pandem
earli
limit
evid
mortal
risk
effect
preexist
comorbid
coronaviru
diseas
import
implic
earli
treatment
object
evalu
risk
preexist
comorbid
mortal
provid
clinic
suggest
accordingli
method
studi
use
nest
casecontrol
design
total
publicli
report
death
locat
outsid
hubei
provinc
china
decemb
th
march
th
includ
case
case
match
three
control
base
gender
age
year
old
case
control
invers
probabl
weight
cox
proport
hazard
model
perform
result
histori
comorbid
significantli
increas
death
risk
one
addit
preexist
comorbid
led
estim
higher
risk
death
p
estim
mortal
risk
patient
chd
three
time
without
chd
p
estim
surviv
probabl
profil
patient
preexist
chd
femal
comorbid
ci
ci
without
chd
older
age
also
associ
increas
death
risk
everi
increas
age
associ
increas
risk
mortal
p
conclus
extra
care
earli
medic
intervent
need
patient
preexist
comorbid
especi
chd
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
sinc
first
report
coronaviru
diseas
decemb
wuhan
hubei
provinc
china
novel
viru
infect
rapidli
spread
citi
china
detect
countri
locat
intern
march
th
world
health
organ
declar
pandem
call
aggress
action
countri
fight
diseas
current
research
indic
caus
sever
acut
respiratori
syndrom
coronaviru
betacoronaviru
similar
sever
acut
respiratori
syndromecoronaviru
sarscov
genet
sequenc
epidemiolog
evid
suggest
initi
report
case
china
histori
exposur
huanan
seafood
market
escal
spread
infect
clear
evid
human
human
transmiss
common
symptom
includ
fever
dri
cough
fatigu
presenc
asymptomat
yet
contagi
case
accord
situat
report
march
th
infect
caus
confirm
case
mainland
china
includ
death
intern
total
confirm
case
report
countri
outsid
china
includ
death
consid
global
public
health
threat
pose
unravel
prognost
factor
patient
especi
risk
factor
mortal
associ
import
implic
clinic
practic
urgent
warrant
studi
indic
sever
case
tend
older
age
like
preexist
medic
condit
includ
limit
hypertens
diabet
cardiovascular
diseas
cerebrovascular
diseas
chronic
obstruct
pulmonari
diseas
copd
cancer
digest
diseas
comparison
nonsever
case
recent
scholarli
attent
focus
identifi
risk
factor
death
evid
suggest
preexist
medic
condit
like
death
risk
factor
covid
exampl
studi
base
case
china
indic
casefat
rate
cfr
tend
higher
among
older
age
preexist
cardiovascular
diseas
diabet
hypertens
compar
patient
similarli
conduct
logist
regress
odd
inhospit
death
among
diseas
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
recov
patient
wuhan
citi
hubei
provinc
zhou
et
al
found
older
age
higher
sequenti
organ
failur
assess
sofa
score
ddimer
greater
hospit
admiss
associ
increas
odd
inhospit
death
found
preexist
hypertens
cardiovascular
complic
common
among
diseas
patient
recov
patient
unpublish
data
howev
sever
gap
remain
understand
risk
factor
mortal
first
current
research
preexist
comorbid
base
univari
comparison
account
import
confound
age
gender
second
studi
investig
hazard
identifi
risk
factor
time
probabl
surviv
given
time
rapidli
chang
pandem
situat
crucial
provid
time
survivaltim
guidanc
implement
target
treatment
highrisk
patient
clinic
practic
third
exist
studi
mortal
risk
factor
focus
patient
diagnos
wuhan
hubei
provinc
littl
understand
mortal
risk
factor
outsid
hubei
provinc
risk
factor
like
differ
insid
outsid
hubei
provinc
sinc
current
research
found
clinic
symptom
sever
fatalitycas
rate
higher
hubei
provinc
center
outbreak
citi
outsid
hubei
provinc
china
fourth
studi
thu
far
taken
account
pandem
stage
evalu
mortal
risk
factor
found
averag
daili
attack
rate
china
differ
januari
th
sinc
nonpharmaceut
intervent
taken
govern
date
chang
pandem
stage
may
also
influenc
risk
factor
fatal
associ
fill
research
gap
exist
literatur
moral
risk
factor
present
studi
conduct
nest
casecontrol
ncc
studi
aim
evalu
risk
common
preexist
comorbid
hypertens
coronari
heart
diseas
diabet
etc
mortal
associ
mainland
china
outsid
hubei
provinc
ncc
also
call
risk
set
sampl
wide
use
studi
fatal
diseas
risk
effect
larg
pharmacoepidemiolog
studi
risk
predict
pandem
influenza
ncc
costeffect
data
collect
especi
suitabl
research
death
risk
diseas
number
eventfre
peopl
larg
exce
experienc
event
attain
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
goal
employ
surviv
analysi
publicli
report
confirm
case
adjust
age
gender
chang
pandem
stage
china
ie
januari
th
studi
perform
surviv
analysi
nest
casecontrol
ncc
design
assess
role
common
comorbid
cardiocerebrovascular
endocrin
respiratori
diseas
etc
predict
mortal
among
patient
mainland
china
outsid
hubei
provinc
studi
period
decemb
th
first
laboratoryconfirm
case
announc
china
till
march
th
studi
cohort
defin
publicli
report
confirm
patient
outsid
hubei
provinc
mainland
china
studi
period
period
death
outsid
hubei
provinc
report
nation
health
committe
china
exclud
present
studi
due
missing
import
clinic
inform
total
publicli
report
laboratoryconfirm
case
death
survivor
initi
collect
data
collect
procedur
blind
patient
comorbid
inform
death
includ
case
case
match
three
control
gender
age
year
old
case
control
sampl
distribut
across
provincelevel
region
mainland
china
present
appendix
tabl
routin
search
daili
news
public
health
report
confirm
case
area
mainland
china
outsid
hubei
provinc
patient
clinic
comorbid
characterist
record
doubli
confirm
nationalprovincialmunicip
health
commiss
websit
offici
data
report
websit
china
followup
time
defin
durat
date
diseas
onset
till
end
observ
march
th
particip
die
whichev
came
first
elig
patient
follow
local
report
updat
surviv
statu
end
followup
time
illustr
figur
inclus
criterion
publicli
report
patient
complet
inform
basic
demograph
age
gender
region
diseas
onset
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
date
first
time
patient
becam
symptomat
histori
comorbid
includ
limit
hypertens
cardiovascular
diseas
diabet
respiratori
diseas
includ
analysi
asymptomat
patient
includ
studi
addit
defin
comorbidityfre
patient
specif
describ
preexist
medic
conditioncomorbid
nationalprovincialmunicip
health
commiss
websit
follow
three
step
use
patient
sampl
exampl
introduc
dynam
track
method
use
identifi
miss
date
step
conduct
internet
search
confirm
case
baiducom
largest
search
engin
china
use
keyword
confirm
case
report
preexist
step
determin
onset
date
patient
base
anoth
announc
websit
announc
titl
possibl
exposur
locat
time
th
confirm
case
say
patient
symptomat
februari
th
step
final
confirm
event
statu
patient
discharg
march
rd
follow
updat
websit
analys
perform
r
r
foundat
statist
comput
baselin
clinic
characterist
shown
mean
sd
median
rang
number
comparison
characterist
subject
stratifi
case
control
via
ttest
continu
variabl
chisquar
fisher
exact
test
binari
variabl
order
util
timetoev
inform
ncc
design
invers
probabl
weight
cox
proport
hazard
regress
model
employ
match
case
control
rel
weight
simultan
obtain
via
kmprob
function
multiplencc
r
packag
specifi
kaplanmei
type
weight
addit
match
gender
age
year
old
survivor
assign
weight
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
sinc
case
death
includ
design
weight
one
survivor
sampl
probabl
zero
consid
fail
match
exclud
studi
total
number
comorbid
defin
summat
comorbid
rang
zero
four
kaplanmei
curv
plot
check
proport
hazard
assumpt
pearson
correl
test
use
rule
multicollinear
concern
fit
model
univari
weight
cox
model
perform
comorbid
multivari
weight
cox
model
use
determin
preexist
comorbid
yield
prognost
hazard
inform
includ
comorbid
margin
signific
p
univari
analysi
multivari
model
common
risk
factor
age
gender
multivari
model
also
adjust
earli
period
pandem
vs
januari
th
nointervent
taken
govern
although
match
base
age
gender
adjust
match
covari
sinc
match
broken
invers
probabl
weight
separ
multivari
model
built
use
total
number
preexist
comorbid
ordin
predictor
adjust
covari
hazard
ratio
hr
weight
cox
model
report
along
confid
interv
ci
pvalu
sensit
analysi
perform
use
multivari
logist
regress
provid
estim
odd
ratio
or
includ
covari
multivari
weight
cox
model
weight
cox
modelbas
surviv
estim
plot
exampl
patient
profil
femal
comorbid
compar
surviv
probabl
time
without
chd
logrank
test
use
compar
median
surviv
differ
studi
approv
shanghai
jiao
tong
univers
public
health
nurs
medic
research
ethic
committe
tabl
summar
patient
demograph
preexist
medic
condit
result
present
patient
studi
well
case
control
respect
patient
year
old
meanag
sdage
averag
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
age
tend
older
case
group
year
old
control
group
year
old
median
age
similar
mean
age
group
major
patient
male
overal
total
patient
clinic
symptom
associ
januari
th
rel
small
proport
total
sampl
copd
renal
failur
histori
surgeri
hepat
failur
among
preexist
comorbid
total
sampl
hypertens
common
follow
diabet
chd
cardiac
failur
cerebr
infarct
chronic
bronchiti
patient
case
group
chd
p
cerebr
infarct
compar
control
group
major
total
sampl
least
one
preexist
comorbid
specif
around
one
two
three
four
compar
control
group
patient
case
group
preexist
comorbid
especi
four
comorbid
p
result
pearson
correl
test
show
signific
correl
among
presenc
comorbid
interest
assumpt
proport
hazard
violat
tabl
present
result
univari
multivari
weight
cox
model
older
age
associ
significantli
higher
death
risk
similar
magnitud
univari
multivari
model
adjust
model
everi
increas
age
associ
estim
higher
risk
death
p
signific
hazard
differ
found
male
femal
patient
diseas
infect
earli
nointervent
period
associ
higher
risk
death
although
statist
signific
increas
number
cumul
comorbid
associ
higher
mortal
risk
unadjust
adjust
model
p
moreov
one
addit
preexist
comorbid
associ
increas
risk
mortal
preexist
comorbid
associ
higher
risk
mortal
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
diabet
chronic
bronchiti
adjust
age
gender
earli
period
pandem
china
chd
comorbid
yield
signific
death
risk
patient
preexist
chd
estim
time
death
risk
without
chd
addit
cerebr
infarct
copd
renal
failur
estim
hr
around
respect
similar
result
observ
use
unweight
logist
regress
sensit
analysi
appendix
tabl
overal
median
followup
day
death
observ
paper
use
surviv
analysi
estim
fatal
risk
preexist
comorbid
base
publicli
report
confirm
case
adjust
confound
effect
age
gender
earli
period
pandem
nointervent
taken
three
major
find
first
histori
comorbid
significantli
increas
death
risk
one
addit
preexist
comorbid
led
estim
increas
death
risk
p
second
adjust
confound
chd
signific
risk
factor
mortal
patient
chd
higher
risk
mortal
compar
patient
without
chd
p
patient
profil
yearold
femal
without
comorbid
estim
median
surviv
time
chd
day
day
without
chd
p
third
older
age
associ
increas
death
risk
specif
everi
increas
age
associ
increas
risk
mortal
p
best
knowledg
present
studi
first
provid
substanti
statist
evid
show
effect
chd
predict
mortal
result
consist
previou
studi
found
higher
casefat
rate
among
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
cardiovascular
diseas
worth
point
exist
studi
investig
prognost
factor
death
use
chisquar
test
univari
logist
regress
control
potenti
confound
contrast
conduct
weight
cox
proport
hazard
regress
model
studi
use
timetoev
outcom
offer
survivaltimerel
inform
help
guid
clinic
intervent
statist
power
detect
risk
factor
previou
studi
indic
cardiovascular
event
follow
pneumonia
may
increas
risk
mortal
explain
find
point
view
pathophysiolog
mechan
one
potenti
mechan
underli
associ
pneumonia
cardiovascular
event
inflamm
specif
inflammatori
reaction
follow
pneumonia
result
plagu
instabl
damag
blood
vessel
evid
elev
local
inflamm
atherosclerot
coronari
arteri
follow
acut
system
infect
shown
mani
studi
thu
infect
may
result
heighten
load
impos
cardiomyocyt
lead
sympathet
hyperact
ischemia
may
increas
risk
arrhythmia
heart
failur
patient
preexist
chd
given
limit
understand
prognost
factor
research
potenti
prospect
studi
need
investig
mechan
preexist
chd
may
influenc
surviv
probabl
among
patient
clinic
point
view
earli
evalu
patient
medic
histori
necessari
implement
earli
medic
intervent
decreas
mortal
risk
suggest
monitor
dynam
heart
rate
patient
preexist
chd
severesymptomat
patient
preexist
heart
ischemia
abnorm
heart
function
earli
medic
intervent
may
need
furthermor
result
indic
hazard
death
significantli
higher
patient
older
age
adjust
other
everi
increas
age
associ
increas
risk
death
similarli
found
previou
studi
alongsid
evid
prognost
risk
chd
suggest
extra
care
need
chd
especi
elderli
patient
design
exclud
patient
hubei
provinc
base
concern
unknown
confound
caus
insuffici
medic
resourc
epicent
cdc
report
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
point
rapidli
increas
number
infect
could
easili
crash
health
care
system
exceed
maximum
capac
therefor
analyz
patient
data
outsid
hubei
provinc
avoid
compet
death
risk
caus
insuffici
health
care
resourc
reveal
true
underli
impact
preexist
comorbid
mortal
one
limit
present
studi
lie
natur
publicli
report
data
research
point
sever
case
may
overrepres
publicli
report
data
nevertheless
manag
reduc
potenti
bia
caus
sever
case
overrepresent
appropri
match
case
control
ncc
design
automatch
procedur
via
statist
program
also
prevent
possibl
tendenti
select
survivor
comorbidityfre
histori
data
collect
addit
ncc
design
favor
situat
risk
factor
data
event
interest
identifi
opportunist
publicli
report
confirm
case
therefor
ncc
optim
choic
given
restrict
avail
public
data
conclus
find
provid
preliminari
yet
strong
evid
support
associ
preexist
chd
mortal
risk
patient
base
find
close
monitor
extra
care
earli
medic
intervent
need
patient
preexist
chd
reduc
mortal
risk
associ
author
affili
involv
organ
entiti
financi
nonfinanci
interest
subject
matter
materi
discuss
manuscript
authorfund
grant
medrxiv
licens
display
preprint
perpetu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
bold
statist
signific
use
threshold
p
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
chdcoronari
heart
diseas
copdchron
obstruct
pulmonari
diseas
bold
statist
signific
use
threshold
p
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
appendix
chdcoronari
heart
diseas
copdchron
obstruct
pulmonari
diseas
bold
statist
signific
use
threshold
p
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
